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With cancer being the leading cause of death in the U.S. and many
patients fall victim to oral mucositis as an adverse side effect, it is
important to find a way to prevent the development of oral mucositis.
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Table 1. Disadvantages of current treatments for oral mucositis.
Table 2. Breakdown of Pattern Recognition Receptors (PRRs)
Pattern recognition receptors (PRRs) are divided into pathogen 
associated molecular patterns (PAMPs) and damage associated 
molecular patterns (DAMPs). 
PAMPs are membrane bound receptors and DAMPs are in the 
cytoplasm 
TLRs and NLRs may play a role in the innate regulation of oral 
mucositis
Oral mucositis presents itself as severe mouth sores, oral and
gastrointestinal ulcers, difficulty swallowing, and redness of the
mouth as a result of cancer treatment with head and neck cancer. Oral
mucositis can disrupt patient treatment. This debilitating side effect
affects approximately 500,000 patients undergoing cancer therapy in
the U.S.
Mucositis follows a five step model that involves the stages of
initiation, upregulation, signaling and amplification, ulceration and
healing. Oral mucositis begins with an innate immune response
which is triggered by a family of Pattern Recognition Receptors
(PRRs). There are four classes of PRRs and the upregulation of
certain PRRs can lead to the prevention of the initiation phase of
mucositis4.
Figure1: severe oral ulcerations that are painful and affect oral functions
Treatment Disadvantage(s)
Cryotherapy1 Development is not prevented
Mouthwashes and Rinses1
Development not prevented, pain 
reduced slightly
Antibiotics: Polymyxin E 
tobramycin and amphotericin B2
Increase risk of toxicity and 
resistance to antibiotics
Accelerated radiotherapy2
Development of influenza. Low 
tolerance for treatment. Persistence 
of severe oral mucositis
Morning radiotherapy2 Toxicity rate not reduced
Povidone iodine2 Patients do not like the taste
Receptors of Inflammation in Human Body New Treatment Approaches 
Traditional Treatment Methods and Disadvantages
Mechanism of Inflammation
Natural Methods of Formulation (7)
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Five Steps Progression of Oral Mucositis6
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• Damage in 
DNA strand
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transcriptio
n factors 
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inflammator
y cytokines 
production
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barrier
• Occurrence 
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Table 3. Model for oral mucositis
Pattern Recognition Receptors for Oral Mucositis
Pathogen Associated Molecular 
Patterns (PAMPs)
Damage Associated Molecular 
Patterns (DAMPs)
• Membrane bound
• Toll-Like Receptors (TLRs)
• C-Type Lectin Receptors (CLRs)
• In cytoplasm
• NOD-Like Receptors (NLRs)
• RIG-Like Receptors (RLRs)
Name Contents Formulation Outcome
MuGard Glycerin, benzyl alcohol, sodium 
saccharin, carbomer 
homopolymer A, potassium 
hydroxide, citric acid, polysorbate 
60, phosphoric acid
Mucoadhesive 
gel topical 
agent
Reduction in 
severity and 
development of 
mucositis and pain
Glutamine Glutamine amino acid Anti-
inflammatory 
agent
Reduction in 
occurrence, severity 
and duration of 
mucositis, 
N-acetyl 
cysteine 
Antioxidant Decrease in severity 
in extreme 
mucositis
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Table 4. Approaches to treatment of oral mucositis5
In summary, oral mucositis is a clinically important, deleterious 
consequence of chemo and radiotherapy, for which no effective 
treatment has been found to date.
Mucositis lesions can be painful, affect nutrition and quality of life, 
and have a significant economic impact.
This review discusses current clinical practices in the management 
of oral mucositis and emphasizes that new approaches need to 
discover new formulations.
Natural Ingredient Type of Use Polymer Nanomaterial Formation
Coffee plus honey Topical and swallow No polymer
The best reduction in severity was 
achieved in coffee plus honey group.
Peppermint Topical (mouthwash) No Polymer
Significant reduction in frequency of 
mucositis
Olive leaf extract Topical (mouthwash) No Polymer
Significant reduction in frequency of 
mucositis
Curcuma longa
Mouthwash and as nano-
formulation
Eudragit and 
Pluronic F68
Future experimentation needed
Resvaterol
Mouthwash and as nano-
formulation
Eudragit and 
Pluronic F69
Future experimentation needed
Qucertin
Mouthwash and as nano-
formulation
Eudragit and 
Pluronic F70
Future experimentation needed
Table 5. Use, polymer, and nanomaterials for natural methods
